BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 19602708)

  • 1. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
    Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
    Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function.
    Fu J; Wang D; Yu Y; Heinrichs J; Wu Y; Schutt S; Kaosaard K; Liu C; Haarberg K; Bastian D; McDonald DG; Anasetti C; Yu XZ
    J Immunol; 2015 Jan; 194(1):388-97. PubMed ID: 25404360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.
    Carlson MJ; West ML; Coghill JM; Panoskaltsis-Mortari A; Blazar BR; Serody JS
    Blood; 2009 Feb; 113(6):1365-74. PubMed ID: 18957685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease.
    Yeh SP; Liao YM; Lo WJ; Lin CL; Bai LY; Lin CY; Hsieh CY; Chang YC; Huang YT; Chiu CF
    PLoS One; 2012; 7(9):e44416. PubMed ID: 22957070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.
    Iclozan C; Yu Y; Liu C; Liang Y; Yi T; Anasetti C; Yu XZ
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):170-8. PubMed ID: 19804837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
    Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4
    Zhang A; Xiong Y; Xu F; Wang Z; Ma J; Zhao N; Hu T; Yi J; Zhou Y; Luan X
    Cell Immunol; 2020 Jun; 352():104113. PubMed ID: 32331794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
    Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
    J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice.
    Pan B; Zhang Y; Sun Y; Cheng H; Wu Y; Song G; Chen W; Zeng L; Xu K
    Cytokine; 2014 Aug; 68(2):69-75. PubMed ID: 24845795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.
    Ding Q; Lu L; Wang B; Zhou Y; Jiang Y; Zhou X; Xin L; Jiao Z; Chou KY
    J Immunol; 2006 Sep; 177(6):3606-14. PubMed ID: 16951320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease.
    Lim JY; Cho BS; Min CK; Park G; Kim YJ; Chung NG; Jeong DC; Min WS
    Immunol Invest; 2014; 43(1):41-53. PubMed ID: 24111544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.
    Foley JE; Mariotti J; Ryan K; Eckhaus M; Fowler DH
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):959-972. PubMed ID: 18721759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.
    Sun K; Hsiao HH; Li M; Ames E; Bouchlaka M; Welniak LA; Hagino T; Jagdeo J; Pai CC; Chen M; Blazar BR; Abedi M; Murphy WJ
    J Immunol; 2012 Aug; 189(4):2033-42. PubMed ID: 22778394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.
    Park MJ; Moon SJ; Lee SH; Yang EJ; Min JK; Cho SG; Yang CW; Park SH; Kim HY; Cho ML
    PLoS One; 2013; 8(6):e67171. PubMed ID: 23840617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
    DiIulio NA; Xu H; Fairchild RL
    Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells.
    Orgun NN; Mathis MA; Wilson CB; Way SS
    J Immunol; 2008 Mar; 180(6):4109-15. PubMed ID: 18322221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
    Rus V; Svetic A; Nguyen P; Gause WC; Via CS
    J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.